ArticleThoracic cancer2026

BMAL1 Drives Cisplatin Resistance in Non-Small Cell Lung Cancer Via Lactate-MRP1 Signaling Pathway.

Zixin Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.